Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2014 Volume 8 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report

Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report

  • Authors:
    • Shun‑Neng Hsu
    • Jia‑Hong Chen
    • Woei‑Yau Kao
  • View Affiliations / Copyright

    Affiliations: Division of Hematology‑Oncology, Department of Medicine, Tri‑Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, R.O.C., Division of Hematology‑Oncology, Department of Medicine, Tri‑Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, R.O.C.
  • Pages: 1831-1833
    |
    Published online on: July 10, 2014
       https://doi.org/10.3892/ol.2014.2341
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The outcomes of matched unrelated donor (MUD) hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST) in patients with severe aplastic anemia (SAA) remain controversial. The clinical outcome in patients that undergo transplantation following failed IST is typically poorer when compared with patients that initially underwent transplantation. Clinical treatment algorithms have been proposed to determine the management of such patients, and account for individual conditions, personal preferences and prognostic risk factors. The present study reports the promising outcome of a 22‑year‑old patient exhibiting SAA. The patient underwent peripheral blood stem cell transplantation (PBSCT) from an MUD using a fludarabine‑based conditioning regimen and low‑dose total body irradiation as an alternative method to first‑line IST. The patient achieved rapid bone marrow reconstitution and has been in complete remission for 32 months. The aim of the fludarabine‑based conditioning regimen with PBSCT was to improve the patient's therapeutic outcome and provide a convenient treatment strategy. Furthermore, this regimen extends the application of HSCT to patients who are older or those that are without a matched related donor.
View Figures

Figure 1

View References

1 

Peinemann F, Grouven U, Kröger N, Pittler M, Zschorlich B and Lange S: Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica. 94:1732–1742. 2009.

2 

Brodsky RA and Jones RJ: Aplastic anaemia. Lancet. 365:1647–1656. 2005.

3 

Young NS, Calado RT and Scheinberg P: Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 108:2509–2519. 2006.

4 

Dezern AE and Brodsky RA: Clinical management of aplastic anemia. Expert Rev Hematol. 4:221–230. 2011.

5 

Bacigalupo A and Marsh JC: Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18–40 years without an HLA-identical sibling and failing immunosuppression. Bone Marrow Transplant. 48:198–200. 2013.

6 

Young NS: Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013:76–81. 2013.

7 

Bacigalupo A: Guidelines for the treatment of severe aplastic anemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT). Haematologica. 79:438–444. 1994.

8 

Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, et al; European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 37:439–449. 2006.

9 

Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, et al; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 123:782–801. 2003.

10 

Marsh J: Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program. 78–85. 2006.

11 

Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 147:43–70. 2009.

12 

Sugihara T: Treatment guideline for aplastic anemia and the actual status of its applications. Nihon Naika Gakkai Zasshi. 97:1698–1705. 2008.(In Japanese).

13 

Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, et al; European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant. 45:219–234. 2010.

14 

Horowitz MM: Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. Semin Hematol. 37:30–42. 2000.

15 

Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, Ribaud P, Devergie A, Traineau R, Gluckman E and Socié G: Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 103:2490–2497. 2004.

16 

Gafter-Gvili A, Ram R, Raanani P and Shpilberg O: Management of aplastic anemia: the role of systematic reviews and meta-analyses. Acta Haematol. 125:47–54. 2011.

17 

Stern M, Passweg JR, Locasciulli A, Socié G, Schrezenmeier H, Békássy AN, et al; Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. Transplantation. 82:218–226. 2006.

18 

Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al: Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 329:1152–1157. 1993.

19 

Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, et al; Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT). Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 97:1142–1148. 2012.

20 

Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, et al: Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol. 162:383–391. 2013.

21 

Kojima S, Nakao S, Young N, Bacigalupo A, Gerard G, Hirano N, et al: The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol. 93:832–837. 2011.

22 

Chen PM, Hsiao LT, Tang JL, Yen CC, Liu JH, Lin KH, et al: Haematopoietic stem cell transplantation in Taiwan: past, present, and future. Hong Kong Med J. 15(3 Suppl 3): S13–S16. 2009.

23 

Shaw CK, Lin CL, Li CC, Lee TD and Tseng WP: Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR). Bone Marrow Transplant. 23:727–730. 1999.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hsu SN, Chen JH and Kao WY: Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncol Lett 8: 1831-1833, 2014.
APA
Hsu, S., Chen, J., & Kao, W. (2014). Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncology Letters, 8, 1831-1833. https://doi.org/10.3892/ol.2014.2341
MLA
Hsu, S., Chen, J., Kao, W."Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report". Oncology Letters 8.4 (2014): 1831-1833.
Chicago
Hsu, S., Chen, J., Kao, W."Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report". Oncology Letters 8, no. 4 (2014): 1831-1833. https://doi.org/10.3892/ol.2014.2341
Copy and paste a formatted citation
x
Spandidos Publications style
Hsu SN, Chen JH and Kao WY: Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncol Lett 8: 1831-1833, 2014.
APA
Hsu, S., Chen, J., & Kao, W. (2014). Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncology Letters, 8, 1831-1833. https://doi.org/10.3892/ol.2014.2341
MLA
Hsu, S., Chen, J., Kao, W."Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report". Oncology Letters 8.4 (2014): 1831-1833.
Chicago
Hsu, S., Chen, J., Kao, W."Allogeneic hematopoietic stem cell transplantation as the first‑line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report". Oncology Letters 8, no. 4 (2014): 1831-1833. https://doi.org/10.3892/ol.2014.2341
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team